We explored whether iron deficiency in the absence of anemia is associated with fatigue in inflammatory bowel disease (IBD).
Introduction
Fatigue is a common concern of individuals suffering from chronic disease (1) . Fatigue has been described extensively in cancer, multiple sclerosis, rheumatologic diseases, chronic kidney disease, and chronic liver disease, among others (2) (3) (4) (5) (6) . It is also quite prevalent in inflammatory bowel disease (IBD) (7) (8) (9) (10) (11) and has been shown to adversely affect quality of life (9) . In population-based samples of individuals with IBD in Canada (8) and the Netherlands (9), problematic fatigue was reported by more than two-thirds of those with active disease (70% (ref. 8) , 76% (ref. 9)), and by 30% (ref. 8) and 37% (ref. 9 ) with inactive disease. Fatigue is not only one of the most common IBD symptoms reported, along with abdominal pain and diarrhea (7) , it is also one of IBD patients' most predominant concerns (12) .
Fatigue may result from a complex interaction of multiple factors, including ongoing systemic inflammation, lack of restorative sleep, chronic pain, and psychological distress (6) , all of which have been linked to fatigue in IBD (5, 8) . Anemia has often been assumed to be a primary causal factor of fatigue. It has been reported to be strongly associated with fatigue in cancer (13, 14) as well as in IBD (9, 10, 15) , although findings are not consistent (5) . The anemia common to patients with IBD is mainly due to iron deficiency from blood loss, either alone or in combination, and suppression of erythropoiesis and iron binding (16, 17) due to proinflammatory cytokine activity. There has been support for aggressively treating anemia in IBD using iron therapy for those who are iron deficient and using erythropoietin for patients with impaired red blood cell production (15, (17) (18) (19) .
However, in the absence of anemia, it is unclear to what extent iron deficiency contributes to symptoms. Could iron deficiency itself be associated with fatigue? A recent systematic review of fatigue in IBD identified iron deficiency as a potential contributing factor to fatigue in IBD and emphasized the need for research to explore this finding (5) . If it were determined that iron deficiency
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Previously, IBD research that assessed iron deficiency either did not define it (20) , used serum ferritin and mean corpuscular volume <66 (21), or used both serum ferritin and transferrin saturation (22) to estimate iron stores. Expert reviews have suggested the use primarily of serum ferritin (with or without transferrin saturation) (17) (18) (19) , with some indicating that the addition of soluble transferrin receptor (sTfR) could enhance the ascertainment of iron deficiency in IBD, considering that serum ferritin is an acutephase reactant and thus can be difficult to interpret in the presence of inflammation (18, 19) . sTfR is thought to be more sensitive than ferritin in detecting iron deficiency, although the incremental utility of this index continues to be debated (23, 24) . That is, the sTfR receptor is elevated in iron-deficient states but is significantly less affected by inflammation than typical iron indexes (ferritin, serum iron and total iron binding capacity, and percentage transferrin saturation) (23, 25, 26) .
In this study, we aimed to investigate the relationship between iron deficiency and fatigue in IBD, in the absence of anemia. We hypothesized that those who were iron deficient would be more likely to experience significant fatigue than those who were iron sufficient, anticipating a more modest relationship overall between iron deficiency and fatigue than between anemia and fatigue. We used a population-based IBD sample that included those with active and quiescent disease, and aimed to broaden and enhance the accuracy of identification of iron-deficient individuals by using an sTfR assay in addition to ferritin measurement.
Methods

Participants.
The Manitoba IBD Cohort Study was initiated in 2002, with participants who were at least 18 years old and had been diagnosed with IBD within the previous 7 years. They were recruited from a validated population-based research registry that has been previously described (27) . The registry identifies and recruits individuals on the basis of an administrative definition of IBD from the comprehensive health database of Manitoba Health, the single insurer that provides health care to all residents in the province. Of those eligible, that is, all those with IBD in the province, just over half participate in the registry. The study was approved by the University of Manitoba Health Research Ethics Board, and participants provided written informed consent.
At the time of recruitment, there were 3,192 individuals in the research registry, of whom 606 were eligible for this study, given the criteria regarding age and recent disease onset. Approximately 14% declined to take part, and another 17% could not be contacted. Complete data were obtained in the first contact from 388 of those enrolled, and they have subsequently served as the cohort, described elsewhere in detail (28) . Population representativeness was assessed by comparison of cohort participants with all other IBD cases diagnosed in the same time period, using a comprehensive validated data set that includes all those in the province with IBD (the University of Manitoba IBD Epidemiology Database). Results indicated there were no significant differences on standard demographic comparisons including mean age, age distribution, sex distribution, urban vs. rural residence, and mean duration of disease, suggesting excellent representativeness (29) .
In the Cohort study, information on core clinical and psychological parameters is obtained every 6 months through survey, and annually through clinical interviews completed by research nurses. New variables or more detailed data collection are added annually. The data for the variables of interest in this study, which included fatigue, disease activity, and iron-related laboratory parameters, were collected concurrently for each participant, 24 months after entry into the longitudinal study. At that point, there were 318 with diagnostic and current disease activity information actively participating in the cohort. The variables for this study were assessed through clinical interview, self-report survey, and blood samples.
Disease type and activity. The diagnosis and subtype of IBD were verified through chart review, which was completed by study staff at physicians' offices. Current disease activity was determined based on standardized clinical indexes obtained during the clinical interview, using the Harvey-Bradshaw for Crohn's disease and the Powell-Tuck for ulcerative colitis (30, 31) . Cutoff levels of ≥5 were used to identify active IBD (32, 33) . a 20-item instrument designed to measure five aspects of current fatigue: general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation (34) . The score on each subscale ranges from 4 to 20, with higher scores indicating greater fatigue. The "general fatigue" subscale is commonly referenced as the primary fatigue descriptor, rather than a total MFI scale score. A cutoff of ≥13 for the "general fatigue" subscale was used to delineate high or problematic fatigue, as has been done in previous IBD studies on the basis of the 95th percentile of the score in a healthy control group (9, 11, 35) .
Anemia and iron deficiency. Anemia was defined as a serum hemoglobin value less than 140 g/l in males and less than 120 g/l in females, per usual laboratory parameters. In this study, iron deficiency was defined on the basis of laboratory assay standards as serum ferritin <20 μg/l or sTfR >28 mg/l, the manufacturer's suggested cutoff, irrespective of ferritin level. Ferritin is known to reflect total body iron stores in states of health but increases in response to inflammation (36) . Measuring sTfR concentration can improve the diagnostic accuracy of iron deficiency, particularly in the setting of inflammation or chronic disease. sTfR is inversely related to intracellular iron stores but is relatively insensitive to inflammation (21) . Subjects were classified as either iron deficient (ferritin <20 μg/l or sTfR >28 mg/l) or iron sufficient (ferritin ≥20 μg/l and sTfR ≤28 mg/l). Iron replete was defined as serum ferritin >100. Ferritin was measured by an immunoturbidimetric assay (Roche Diagnostics, Laval, QC).
The sTfR was measured with a commercially available human sTfR enzyme-linked immunosorbent assay (Quantikine IVD, R&D Systems, Minneapolis, MN).
Statistical analysis.
Mean hemoglobin and ferritin levels were compared between disease types and between disease activity statuses, by two-tailed t-tests. Proportions with or without anemia and iron deficiency were also compared between disease types and between disease activity statuses by c 2 tests. We then explored the relationship between iron deficiency and fatigue among the subset of those who were nonanemic. Mean levels of fatigue, considering different domains of fatigue, for the iron-deficient and iron-sufficient groups were compared by two-tailed t-tests. Fisher's exact tests were used to compare proportions of those with significant fatigue with and without iron deficiency. Where necessary, a Bonferroni correction was used to correct for multiple comparisons. A secondary analysis using Fisher's exact test was conducted to compare proportions with high fatigue in two distinct ferritin groups to ensure there was no overlap: those with serum ferritin <20 (iron deficient) and those with serum ferritin ≥100 (iron replete). Parallel analyses were also done regarding fatigue and iron deficiency with the anemic subgroup. Finally, multivariate logistic regression was used to assess the relationship between fatigue and iron deficiency, first assessing each of the clinical factors individually (i.e., active disease, anemia, and iron deficiency) with fatigue, adjusting for sex and age, and then, in a second model, assessing the impact of all three of the clinical factors on fatigue, concurrently adjusting for each, in addition to adjusting for sex and age.
Results
Complete laboratory values were not available for 29 participants; an additional 9 had incomplete fatigue or disease activity data (Figure 1) . For the remaining 280, the mean age was 44 (s.d. 14.82), and the sample ranged from 19 to 85 years old. Disease duration was, on average, 6.3 years (s.d. 2.1) at the time of this study. The sample was 62% female, and 90% were Caucasian, with a minority having self-described backgrounds as Métis (of Aboriginal and European ancestry), Hispanic, or East Indian. One quarter of the sample reported having a university degree. Most respondents were in a partner relationship (married or common law, 69%) and employed full or part time (68%). Fifty-one percent (143) had Crohn's disease, and the remainder (137) had ulcerative colitis. Forty-six percent (n = 128) had current active disease, based on the Harvey-Bradshaw or the Powell-Tuck clinical index. 
Anemic and iron deficient 7 (5) 11 (8) 15 (9) 5 (4) P = 1.0 P = 0.85
Anemic and iron sufficient 12 (8) 9 (7) 10 (6) 4 (3) P = 0.31 P = 0.54
Nonanemic and iron deficient 10 (7) 11 (8) 15 ( Comparisons between active and inactive disease, collapsing across CD/uC; comparisons are based on t-test and c 2 test where applicable. *P = 0.04 is not significant after bonferroni correction (P ≤ 0.02).
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Eighteen percent overall were anemic, and 23% overall were iron deficient. There were no significant differences in mean hemoglobin, ferritin, or sTfR levels for those with Crohn' s disease or ulcerative colitis ( Table 1) . Comparing inactive to active disease, there were no significant differences in mean ferritin or sTfR levels. Those with active disease had lower mean hemoglobin levels than those with inactive disease, but the difference did not reach the significance threshold after Bonferroni correction ( Table 1 ) (P = 0.04). Considering total proportions with anemia or iron deficiency, there were no significant differences, comparing disease subtypes, or comparing active and inactive disease ( Table 1) .
Of the total sample, 14% were identified as nonanemic and iron deficient, and 68% had neither anemia nor iron deficiency. There were no significant differences between Crohn' s disease and ulcerative colitis or between those with active and inactive disease regarding proportions who were anemic with and without iron deficiency, or proportions who were nonanemic with and without iron deficiency ( Table 1) .
The primary outcome of interest was the relationship of fatigue with iron levels, comparing those who were iron deficient (n = 39) with those who were iron sufficient (n = 191) in the IBD subgroup of those without anemia (n = 230). There were no mean differences in types of fatigue (e.g., physical, mental) or fatigue outcomes (e.g., reduced activity) between the iron-deficient and iron-sufficient groups ( Table  2) . Further, while 49% with iron deficiency had problematic or high fatigue, a similar proportion without any iron deficiency also had problematic fatigue (45%) ( Table 2) . When the distinct ferritin subgroups were compared (i.e., those with serum ferritin <20 vs. those with serum ferritin ≥100), there was no significant difference in the proportions who had problematic fatigue (iron deficient 42% vs. iron replete 58%; P = 0.36; data not shown in table).
The relationship of iron levels and fatigue was also assessed in the subgroup of those with anemia (n = 50). While a large proportion of those who were anemic and iron deficient (n = 26) reported problematic fatigue (62%), just over half of those with anemia who were iron sufficient (n = 24) also reported problematic fatigue (54%), and the differences were not significant (P = 0.78) (data not shown).
Considering hemoglobin levels in relation to fatigue for the whole sample, those with high fatigue had a lower mean serum hemoglobin (134.5; s.d. 14.0) than those without fatigue (mean serum hemoglobin 138.1; s.d. 13.5; P = 0.03), but the difference was not significant after Bonferroni correction. Table 3 shows the multivariate logistic regressions, all of which were adjusted for age and sex. Each of the clinical factors-active disease, anemia, and iron deficiency-was first assessed separately to determine their contribution to fatigue. Problematic fatigue was almost seven times more likely to occur during active disease (odds ratio 6.9, 95% confidence interval 4.0-11.8) but was not significantly more likely to occur with anemia or iron deficiency. Further, in the full multivariate analysis (model 2), when age, sex, active disease, and anemia were controlled for, iron deficiency did not uniquely contribute to the likelihood of significant fatigue (adjusted odds ratio 1.1, 95% confidence interval 0.6-2.
2).
Discussion
In what we believe to be the first study to date exploring the relationship between iron deficiency and fatigue in nonanemic people with IBD, we were not able to establish any relevant association between iron deficiency and fatigue. Two previous IBD-related studies reported that anemia was associated with fatigue, although they had not measured iron deficiency. Using the same fatigue measure as we did, a population-based Dutch study found that anemia correlated with fatigue in ulcerative colitis patients but not in Crohn's disease (9) , and in a single-center Norwegian study, anemia was significantly associated with chronic fatigue (i.e., fatigue for at least 6 months measured by the Fatigue Questionnaire) (37) . A report from Scandinavia, based on 425 outpatients, assessed both anemia and iron deficiency. Similar to our findings, they reported that 44% of all subjects were fatigued, while 19% were anemic, and 34% were iron deficient. This study used a more liberal definition than our study (ferritin <30 μg/l). Anemia was not associated with fatigue, and neither was iron deficiency, although the investigators did not distinguish the role of iron deficiency in the absence of anemia (11) . In our study, serum hemoglobin levels were lower for those with problematic fatigue; however, the difference did not reach significance, and mean levels were only mildly below the clinical threshold.
The issue of whether iron deficiency in the absence of anemia, or even anemia itself, has negative sequelae related to fatigue or other cognitive processes has been the focus of some randomized controlled studies, dating back as far as 1960 (38) (39) (40) , with inconclusive results. Older reviews argued that iron deficiency was important in childhood cognitive development and adult exercise tolerance (41, 42) . While the authors made the case that iron deficiency anemia was clearly detrimental, it was not established whether iron deficiency in the absence of anemia was detrimental. More recent findings from controlled studies in healthy women have suggested a link between iron deficiency and fatigue (43) (44) (45) (46) , and learning and memory (47) . These studies collectively indicate a relationship between iron deficiency and fatigue in healthy women and suggest a role for iron in fatigue reduction, at least in the environment of a depleted iron state. However, in the context of IBD, the relationship between iron deficiency and fatigue was not evident in our study. It may be that the studies showing a benefit of iron supplementation for fatigue suffer from the difficulty of blinding-oral iron supplementation turns stools black (43) (44) (45) , and intravenous iron infusion was associated with much higher side effects than the placebo (46) . Blinding or lack thereof may be especially important in measuring a subjective outcome such as fatigue. Perhaps in the presence of chronic disease, whether active or in remission, other processes related to stress or sleep disturbances may play a greater contributory role toward fatigue in IBD than measurable iron levels (8) . It should be noted that iron sequestration, and thus possibly iron deficiency in the setting of prolonged chronic illness, is a genetically determined adaptive response to sickness (48) . The mechanism of iron deficiency in IBD patients and subsequent response to iron supplementation may therefore be fundamentally different from iron deficiency seen in healthy women. Though speculative, given the role of iron in the generation of hydroxyl free radical and unstable oxygen species via the Fenton reaction (49) , iron sequestration may represent an appropriate adaptation to chronic illness and thus obscure the relationship of iron deficiency and fatigue observed in other contexts.
This study used a population-based rather than a clinical IBD sample, which has the advantage of greater generalizability to the range of experience of those living with IBD. However, as the rates of anemia we found were lower than what has been reported in clinical IBD samples, it is possible there was insufficient power to detect a significant relationship. In addition, we used measures of iron stores (serum ferritin) as well as sTfR, to more comprehensively assess iron status. While serum ferritin levels have been the mainstay to determine iron deficiency in most of the previous studies in healthy women, there is no clear consensus on the optimal definition of iron status that provides clinically relevant information in a population with a chronic inflammatory disease. It is certainly possible that measurement of iron stores is not accurate or precise enough to delineate a potentially subtle relationship between iron deficiency and fatigue. Because there is some uncertainty about the utility of sTfR, we also assessed the fatigue and iron deficiency relationships by comparing those more highly likely to be iron deficient (serum ferritin <20 μg/l) and those more highly likely to be iron replete (serum ferritin >100 μg/l), and there was still no difference in significant fatigue in those groups. Finally, while disease activity was assessed through available clinical indexes, the potential that subtle degrees of inflammation, relevant to iron metabolism or fatigue, might bias the result of this study (differentially or toward the null) is unknown but cannot be excluded.
In conclusion, our data suggest that, at least for people with IBD, iron deficiency in the absence of anemia does not correlate with clinically relevant fatigue. Clinical trials designed to assess the efficacy and safety of iron supplementation for the treatment of fatigue in this patient population are needed before this therapeutic strategy can be endorsed.
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